Form 4: Intuitive Surgical SVP Mark Brosius Sells Shares Under 10b5-1 Trading Plan

Mark Brosius, SVP & Chief Manufacturing and Supply Chain Officer at Intuitive Surgical, sold 392 shares of ISRG common stock in two transactions on March 8 and March 11, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Mark Brosius, a Senior Vice President at Intuitive Surgical, sold shares of the company's common stock.
• The sales occurred on March 8 and March 11, 2024.
• A total of 392 shares were sold in two transactions.
• The sales were executed under a pre-arranged trading plan that complies with SEC Rule 10b5-1.
• The trading plan expires on June 7, 2024.
• On March 8, 196 shares were sold at a price of $392.02 per share.
• On March 11, 196 shares were sold at a price of $390.16 per share.
• Following the reported transactions, Brosius directly owns 1,058 shares of Intuitive Surgical stock.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock sales by an executive, executed under a pre-existing trading plan. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

Sales by executives are a normal part of corporate compensation and wealth management. The use of a 10b5-1 trading plan indicates that these sales were pre-planned and not based on any inside information.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely to be minimal given the relatively small number of shares sold.

Key Dates